We are live on ! Find out more
ECM

ExodusPoint Capital Management Portfolio holdings

AUM $12.6B
1-Year Est. Return 30.13%
This Fund
S&P 500
This Quarter Est. Return
+27.17%
1 Year Est. Return
+30.13%
3 Year Est. Return
+85.63%
5 Year Est. Return
+104.04%
10 Year Est. Return
AUM
$3.85B
AUM Growth
+$2.03B
Cap. Flow
+$1.66B
Cap. Flow %
43.05%
Top 10 Hldgs %
17.46%
Holding
2,172
New
1,142
Increased
418
Reduced
161
Closed
448

Sector Composition

Rank Sector Weight
1 Technology 15%
2 Healthcare 9.88%
3 Industrials 9.44%
4 Financials 9.06%
5 Consumer Discretionary 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BF.A icon
1701
Brown-Forman Class A
BF.A
$13.3B
$28K ﹤0.01%
494
+168
+52% +$9.8K
KA
1702
DELISTED
Kineta, Inc. Common Stock
KA
$27K ﹤0.01%
140
+48
+52% +$9.8K
TDAY
1703
USA Today Co
TDAY
$1.06B
$24K ﹤0.01%
17,646
+4,810
+37% +$6.34K
LODE icon
1704
Comstock
LODE
$245M
$23K ﹤0.01%
2,397
XXII
1705
22nd Century Group
XXII
$1.48M
0
FSTX
1706
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$23K ﹤0.01%
+3,988
New +$23.1K
EXPR
1707
DELISTED
Express, Inc.
EXPR
$22K ﹤0.01%
+705
New +$26K
MUX icon
1708
McEwen Inc
MUX
$1.18B
$21K ﹤0.01%
+2,091
New +$19.4K
OGI
1709
Organigram Holdings
OGI
$139M
$20K ﹤0.01%
+3,171
New +$21.4K
HTZ
1710
DELISTED
Hertz Global Holdings, Inc.
HTZ
$20K ﹤0.01%
14,289
-2,680
-16% -$8.51K
NE
1711
DELISTED
Noble Corporation
NE
$20K ﹤0.01%
+62,521
New +$16.1K
MTNB icon
1712
Matinas BioPharma
MTNB
$1.81M
$16K ﹤0.01%
422
-6,061
-93% -$232K
PTN
1713
Palatin Technologies
PTN
$13.8M
$16K ﹤0.01%
+26
New +$16.2K
VAL
1714
DELISTED
Valaris plc Class A Ordinary Share
VAL
$13K ﹤0.01%
+19,558
New +$11.1K
LCTX icon
1715
Lineage Cell Therapeutics
LCTX
$278M
$12K ﹤0.01%
+13,224
New +$11.6K
WLL
1716
DELISTED
Whiting Petroleum Corporation
WLL
$12K ﹤0.01%
+147
New +$11.5K
LEE icon
1717
Lee Enterprises
LEE
$182M
$11K ﹤0.01%
+1,129
New +$10.8K
DXYN
1718
DELISTED
Dixie Group Inc
DXYN
$11K ﹤0.01%
12,456
ACOR
1719
DELISTED
Acorda Therapeutics
ACOR
$11K ﹤0.01%
+128
New +$13.5K
ONDK
1720
DELISTED
On Deck Capital, Inc.
ONDK
$11K ﹤0.01%
+15,089
New +$14.8K
SONM icon
1721
DNA X Inc
SONM
$5.63M
$9K ﹤0.01%
+6
New +$9.58K
CVEO icon
1722
Civeo
CVEO
$318M
$8K ﹤0.01%
1,146
-646
-36% -$3.98K
NKLA
1723
DELISTED
Nikola Corporation Common Stock
NKLA
$5K ﹤0.01%
+3
New +$2.89K
BMY.RT
1724
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1K ﹤0.01%
+198
New +$714
AA icon
1725
Alcoa
AA
$13.2B
-83,994
Closed -$517K

Similar funds

ExodusPoint Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, ExodusPoint Capital Management held 2,172 positions worth $3.85B, up 111% from $1.82B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

ExodusPoint Capital Management deployed $1.66B of net new capital in Q2 2020, opening 1,142 new positions and adding to 418 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 266,338 shares worth $82.1M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Amazon, an estimated $27.8M trimmed.

  • ExodusPoint Capital Management's largest Q2 2020 buy was State Street SPDR S&P 500 ETF Trust: 266,338 shares worth $82.1M.
  • ExodusPoint Capital Management added most to PG&E in Q2 2020, an estimated $38.2M increase.
  • ExodusPoint Capital Management's biggest Q2 2020 reduction was Amazon, cutting an estimated $27.8M.
  • ExodusPoint Capital Management fully exited McKesson in Q2 2020, selling an estimated $18.1M.
  • ExodusPoint Capital Management's ten largest holdings make up 17% of its $3.85B portfolio in Q2 2020.
  • ExodusPoint Capital Management opened 1,142 new positions and closed 448 in Q2 2020.
  • ExodusPoint Capital Management's portfolio value rose 111% quarter-over-quarter to $3.85B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.